American Cancer Society (ACS)/American Society of Clinical Oncology Breast Cancer Survivorship
The purpose of the American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline is to provide recommendations to assist primary care and other clinicians in the care of female adult survivors of breast cancer.
To view the guideline, click here. To view the CME Online Continuing Education Activity, please click here.
American Cancer Society Colorectal Cancer Survivorship Care Guidelines
Colorectal cancer (CRC) is the third most common cancer and third leading cause of cancer death in both men and women and second leading cause of cancer death when men and women are combined in the United States (US). Almost two-thirds of CRC survivors are living 5 years after diagnosis. Considering the recent decline in both incidence and mortality, the prevalence of CRC survivors is likely to increase dramatically over the coming decades with the increase in rates of CRC screening, further advances in early detection and treatment and the aging and growth of the US population. Survivors are at risk for a CRC recurrence, a new primary CRC, other cancers, as well as both short-term and long-term adverse effects of the CRC and the modalities used to treat it. CRC survivors may also have psychological, reproductive, genetic, social, and employment concerns after treatment. Communication and coordination of care between the treating oncologist and the primary care clinician is critical to effectively and efficiently manage the long-term care of CRC survivors. The guidelines in this article are intended to assist primary care clinicians in delivering risk-based health care for CRC survivors who have completed active therapy.
To view these guidelines, please click here.
American Society of Clinical Oncology (ASCO) Treatment Guidelines
The American Society of Clinical Oncology (ASCO) has clinical practice guidelines that serve as a guide for doctors and outline appropriate methods of treatment and care. Guidelines may address specific clinical situations (disease-oriented) or use of approved medical products, procedures, or tests (modality-oriented).
To view a listing of the ASCO Clinical Guidelines, please click here.
Commission on Cancer (CoC) 2016 Cancer Program Standards
The Commission on Cancer (CoC) is a consortium of professional organizations dedicated to improving survival and quality of life for cancer patients. CoC released the 2016 edition of the Cancer Program Standards: Ensuring Patient-Centered Care.
To view the Brief Summary of 2016 Edition Revisions, please click here.
To view the CoC Cancer Program Standards 2016, please click here.
Commission on Cancer (CoC) 2012 Cancer Program Standards
The Commission on Cancer (CoC) is a consortium of professional organizations dedicated to improving survival and quality of life for cancer patients. CoC released A Resource Guide for COC-ACCREDITED FACILITIES: MEETING THE COMMISSION ON CANCER PATIENT-CENTERED STANDARDS in January 2015. These updated standards emphasize patient-centered needs and bring an additional focus on the quality of care and outcomes.
To view this resource guide, please click here.
To view the CoC Cancer Program Standard 2012, please click here.
Institute of Medicine (IOM) Guidelines
In September 2013, the Institute of Medicine (IOM) released a report entitled “Delivering High-Quality Cancer Care: Charting a New Course for a System in Crisis”. Delivery of cancer care in the U.S. is facing a crisis stemming from a combination of factors - a growing demand for such care, a shrinking oncology work force, rising costs of cancer care, and the complexity of the disease and its treatment. The report provides guidelines and recommendations to respond to these challenges and improve cancer care delivery. Some recommendations include strengthening clinicians’ core competencies in caring for patients with cancer, shifting to team-based models of care, and communicating more effectively with patients.
To view the IOM report, please click here.
National Comprehensive Cancer Network® (NCCN®) Cancer Guidelines
The National Comprehensive Cancer Network® (NCCN®) is a not-for-profit alliance of twenty-one of the world's leading cancer centers dedicated to improving the quality and effectiveness of care provided to patients with cancer. The primary goal of all NCCN initiatives is to improve the quality, effectiveness, and efficiency of oncology practice so patients can live better lives.
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) - the recognized standard for clinical policy in oncology - are the most comprehensive and most frequently updated clinical practice guidelines available in any area of medicine. NCCN Guidelines® have become the most widely used guidelines in oncology practice and have been requested by cancer care professionals in more than 115 countries.
To view the NCCN Guidelines, please click here. *Access to the NCCN Guidelines is FREE. Log-in is required.
To access a virtual library of NCCN Guidelines using a free phone app, click here.
NCCN Guidelines for Patients™ are also available at: www.nccn.org/patients.
Prostate Cancer Survivorship Care Guideline: American Society of Clinical Oncology Clinical Practice
The guideline aims to optimize health and quality of life for the post-treatment prostate cancer survivor by comprehensively addressing components of follow-up care, including health promotion, prostate cancer surveillance, screening for new cancers, long-term and late functional effects of the disease and its treatment, psychosocial issues, and coordination of care between the survivor’s primary care physician and prostate cancer specialist.
To view these guidelines, click here.